z-logo
open-access-imgOpen Access
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
Author(s) -
Zerrin Karaaslan,
Murat Kürtüncü,
Halil İbrahim Akçay,
Tuncay Gündüz,
Burcu Altunrende,
Recai Türkoğlu,
Mefküre Eraksoy,
Canan Ulusoy,
Vuslat Yılmaz,
Erdem Tüzün
Publication year - 2021
Publication title -
european neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 77
eISSN - 1421-9913
pISSN - 0014-3022
DOI - 10.1159/000517770
Subject(s) - fingolimod , multiple sclerosis , medicine , psychology , physical medicine and rehabilitation , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here